Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-reperfusion SGLT2 inhibitor in acute myocardial infarction
TCTR20200306004Phase 3Completed
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Dec 2021
- Countries
- 1
01
Overview
Phase 3 trial in myocardial infarction (MI), sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoints: Infarct size and Ventricular function. Started Dec 2021; status: completed.
02
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on TCTR20200306004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200306004.